GIP/GLP-1 agonists, such as Mounjaro and Zepbound, are medications that mimic natural hormones in the gut. They work by controlling appetite, improving insulin response, and slowing digestion, which collectively support significant weight loss.

Mounjaro activates both the GIP and GLP-1 receptors to suppress hunger and regulate blood glucose levels. Florida patients using Mounjaro under medical supervision have experienced rapid and sustained weight loss with weekly injections.

Yes, Zepbound (tirzepatide) is FDA-approved for the treatment of chronic weight management. It’s prescribed for individuals with obesity or overweight with at least one weight-related condition, such as high blood pressure or type 2 diabetes.

Ideal candidates have a BMI over 30, or 27+ with conditions like hypertension, insulin resistance, or high cholesterol. A full consultation is required at Collective Aesthetics to determine eligibility.

Most patients begin to see noticeable weight loss within 4 to 8 weeks, with significant fat reduction over 3 to 6 months. Results vary depending on dosage, lifestyle, and individual metabolism.

While the medication is powerful on its own, combining it with a healthy diet and moderate exercise significantly enhances its effectiveness. Our Florida-based team provides guidance to support long-term lifestyle changes.

Both are once-weekly subcutaneous injections. During your visit to Collective Aesthetics, we will train you to self-administer the shot safely and comfortably at home.

Common side effects include nausea, constipation, or fatigue, especially in the early stages. These typically resolve as your body adjusts to the change. Our team monitors your progress to ensure safety.

Coverage depends on your provider and whether you meet specific medical criteria. We can assist with prior authorizations or offer self-pay options for Florida residents.

GIP/GLP-1 dual agonists target two gut hormones, enhancing both insulin sensitivity and appetite control. This dual mechanism often results in greater weight loss compared to GLP-1-only options, such as Ozempic or Wegovy.

Yes, many patients transition to Mounjaro/Zepbound for better results. We will evaluate your current medication, weight loss progress, and medical history to make a safe transition plan.

Treatment duration varies, but most patients stay on the medication for 3 to 12 months, depending on their weight loss goals. Long-term maintenance may be considered on a case-by-case basis.

You can book directly with Collective Aesthetics, a trusted provider offering medically supervised weight loss programs. Please schedule a consultation through our Contact Page.

Patients should avoid overeating, alcohol, and dehydration. Staying consistent with injections and attending follow-up visits are crucial for achieving optimal outcomes and ensuring safety.

Florida patients commonly lose 15–25% of their body weight over several months, experience increased energy, and see a reduced risk of chronic disease. Every case is tailored to achieve the best possible outcomes.